ERBB2 and neoplasm: Considering T-DM1 as a whole, there are multiple mechanisms for the resistance of tumor cells to T-DM1, including inefficient internalization of the HER2-T-DM1 complex, defective endosomal trafficking after internalization, and further insufficient lysosomal degradation (Barok et al., 2014).